Squarepoint
HELP icon

Squarepoint’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Squarepoint’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$615K Buy
+50,076
New +$523K ﹤0.01% 3214

Other funds holding HELP

DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Premier Fund Managers
Premier Fund Managers Guildford, United Kingdom $978M AUM 14.27% 1-Year Est. Return
ACPLP
ACT Capital Partners, L.P. Wayne, Pennsylvania $154M AUM
WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
PDS Planning
PDS Planning Dublin, Ohio $1.77B AUM 16.76% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Squarepoint's HELP Position: Q3 2026 in Review

Squarepoint opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q3 2026: 50,076 shares worth $615K. The stake represents ﹤0.01% of the portfolio and ranks #3214 among its holdings.

40 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • Squarepoint held 50,076 shares of Helus Pharma Inc. Common Stock worth $615K as of Q3 2026.
  • Helus Pharma Inc. Common Stock was a new Squarepoint position in Q3 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3214 holding.
  • 40 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.